Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P F Conte

Showing results (141-150 of 200) with videos related to

Pageof 20
Sort By:
American Journal of Clinical Oncology|October 1, 1987
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Oncology|January 1, 1989
Evaluation of the ovarian cancer antigen, Ca-125, as a tumor markerM Onetto, M Bruzzone, P F Conte, et al.
Tumori|April 25, 2000
Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II studyM Bertuccelli, A Falcone, S Campoccia, et al.
Cancer|March 5, 1998
Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinomaC Bengala, I Pazzagli, C Tibaldi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studiesA Falcone, R Danesi, L Zaccaro, et al.
British Journal of Cancer|July 9, 2009
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II TrialN Tubiana-Mathieu, P Bougnoux, D Becquart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancerJ T Roberts, H von der Maase, L Sengeløv, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancerP F Conte, M Bruzzone, S Chiara, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study GroupA A Fauser, B Duclos, A Chemaissani, et al.
Anticancer Research|September 1, 1995
Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility studyL Del Mastro, M Venturini, P G Giannessi, et al.
Pageof 20

Showing results (141-150 of 200) with videos related to

Sort By:
Pageof 20
American Journal of Clinical Oncology|October 1, 1987
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Oncology|January 1, 1989
Evaluation of the ovarian cancer antigen, Ca-125, as a tumor markerM Onetto, M Bruzzone, P F Conte, et al.
Tumori|April 25, 2000
Intrahepatic chemotherapy with floxuridine, leucovorin and dexamethasone in continuous infusion and mitomycin-C bolus in unresectable hepatic metastases from colorectal cancer: a phase II studyM Bertuccelli, A Falcone, S Campoccia, et al.
Cancer|March 5, 1998
Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinomaC Bengala, I Pazzagli, C Tibaldi, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Synergistic antiproliferative activity of suramin and alpha 2A-interferon against human colorectal adenocarcinoma cell lines: in vitro studiesA Falcone, R Danesi, L Zaccaro, et al.
British Journal of Cancer|July 9, 2009
All-oral combination of oral vinorelbine and capecitabine as first-line chemotherapy in HER2-negative metastatic breast cancer: an International Phase II TrialN Tubiana-Mathieu, P Bougnoux, D Becquart, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 30, 2006
Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancerJ T Roberts, H von der Maase, L Sengeløv, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancerP F Conte, M Bruzzone, S Chiara, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study GroupA A Fauser, B Duclos, A Chemaissani, et al.
Anticancer Research|September 1, 1995
Intraperitoneal infusion of recombinant human tumor necrosis factor and mitoxantrone in neoplastic ascites: a feasibility studyL Del Mastro, M Venturini, P G Giannessi, et al.
Pageof 20